OAM
LGND icon

Oxford Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Oxford Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,281
Closed -$409K – 798
2019
Q4 		$409K Buy
+6,281
New +$420K 0.01% 1320
2018
Q3 		– Sell
-11,671
Closed -$1.51M – 1828
2018
Q2 		$1.51M Sell
11,671
-3,522
-23% -$393K 0.03% 827
2018
Q1 		$1.56M Sell
15,193
-9,137
-38% -$904K 0.03% 706
2017
Q4 		$2.09M Buy
24,330
+6,293
+35% +$545K 0.05% 549
2017
Q3 		$1.52M Sell
18,037
-4,589
-20% -$363K 0.03% 751
2017
Q2 		$1.71M Buy
+22,626
New +$1.58M 0.03% 674
2016
Q2 		– Sell
-58,235
Closed -$3.89M – 840
2016
Q1 		$3.89M Buy
58,235
+13,391
+30% +$814K 0.11% 228
2015
Q4 		$3M Buy
+44,844
New +$2.77M 0.07% 308
2015
Q2 		– Sell
-71,418
Closed -$3.44M – 698
2015
Q1 		$3.44M Sell
71,418
-292,453
-80% -$11.2M 0.09% 262
2014
Q4 		$12.1M Buy
363,871
+4,509
+1% +$147K 0.27% 60
2014
Q3 		$10.5M Buy
359,362
+129,760
+57% +$4.31M 0.24% 85
2014
Q2 		$8.85M Buy
229,602
+1,976
+0.9% +$80.2K 0.29% 85
2014
Q1 		$9.55M Buy
227,626
+34,827
+18% +$1.45M 0.28% 109
2013
Q4 		$6.33M Buy
+192,799
New +$6.28M 0.16% 190
2013
Q3 		– Sell
-143,308
Closed -$3.35M – 852
2013
Q2 		$3.35M Buy
+143,308
New +$2.58M 0.09% 355

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Oxford Asset Management's LGND Position: Q1 2020 in Review

Oxford Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2020, closing a stake of 6,281 shares — an estimated $409K sold.

Oxford Asset Management first reported a position in LGND in Q2 2013 and held it in 15 quarters. The position peaked at $12.1M in Q4 2014. 262 funds tracked by Wall St. Rank hold LGND as of Q1 2020.

  • Oxford Asset Management reported no remaining Ligand Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 6,281 Ligand Pharmaceuticals shares in Q1 2020, an estimated $409K.
  • Oxford Asset Management first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Oxford Asset Management's Ligand Pharmaceuticals position peaked at $12.1M in Q4 2014.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.